Recurrent Episodes of Fluid Retention in a Patient with Heart Failure and Chronic Kidney Disease: The Additional Value of Implantable Monitoring Systems

<div>(a) ePAD (mmHg). (b) Intrathoracic impedance (<i>Ω</i>) with reference line (dotted). (c) Diuretic dose (bumetanide, mg/day). AE: adverse event. Dashed line indicates loss of ePAD data.</div>

Case Reports in Cardiology

fig2

Figure 2

Figure 2: Recurrent Episodes of Fluid Retention in a Patient with Heart Failure and Chronic Kidney Disease: The Additional Value of Implantable Monitoring Systems 

Figure 2 | Recurrent Episodes of Fluid Retention in a Patient with Heart Failure and Chronic Kidney Disease: The Additional Value of Implantable Monitoring Systems 